ZA96303B - Tricyclic benzazepine vasopressin antagonists - Google Patents

Tricyclic benzazepine vasopressin antagonists

Info

Publication number: ZA96303B
Authority: ZA; South Africa
Prior art keywords: vasopressin antagonists; tricyclic benzazepine; benzazepine vasopressin; tricyclic; antagonists
Prior art date: 1995-01-17

Application number

ZA96303A

Inventor

Aranapakam M Venkatesan

Jay D Albright

George T Grosu

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-17

Filing date

1996-01-15

Publication date

1997-07-15

1996-01-15 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1997-07-15 Publication of ZA96303B publication Critical patent/ZA96303B/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

ZA96303A 1995-01-17 1996-01-15 Tricyclic benzazepine vasopressin antagonists ZA96303B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/373,125 US5521173A (en)	1995-01-17	1995-01-17	Tricyclic benzazepine vasopressin antagonists

Publications (1)

Publication Number	Publication Date
ZA96303B true ZA96303B (en)	1997-07-15

Family

ID=23471074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA96303A ZA96303B (en)	1995-01-17	1996-01-15	Tricyclic benzazepine vasopressin antagonists

Country Status (24)

Country	Link
US (2)	US5521173A (en)
EP (1)	EP0805813B1 (en)
JP (2)	JP4156664B2 (en)
CN (1)	CN1052725C (en)
AR (1)	AR002021A1 (en)
AT (1)	ATE217625T1 (en)
AU (1)	AU707881B2 (en)
BR (1)	BR9607177A (en)
CA (1)	CA2210708C (en)
CZ (1)	CZ224797A3 (en)
DE (1)	DE69621225T2 (en)
DK (1)	DK0805813T3 (en)
EA (1)	EA000056B1 (en)
ES (1)	ES2175066T3 (en)
HK (1)	HK1003891A1 (en)
HU (1)	HUP9702459A3 (en)
IL (1)	IL116774A (en)
MX (1)	MX9705414A (en)
NZ (1)	NZ301198A (en)
PT (1)	PT805813E (en)
TW (1)	TW472056B (en)
UA (1)	UA48960C2 (en)
WO (1)	WO1996022292A1 (en)
ZA (1)	ZA96303B (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5736540A (en) *	1993-07-29	1998-04-07	American Cyanamid Company	Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5753648A (en) *	1995-01-17	1998-05-19	American Cyanamid Company	Tricyclic benzazepine vasopressin antagonists
US5700796A (en) *	1995-01-17	1997-12-23	American Cyanamid Company	Tricyclic benzazepine vasopressin antagonists
US5880122A (en) *	1996-11-01	1999-03-09	American Home Products Corporation	3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines
CA2285343A1 (en)	1997-03-31	1998-10-08	Wakamoto Pharmaceutical Co., Ltd.	Biphenyl derivatives and medicinal compositions
US6194407B1 (en)	1997-07-30	2001-02-27	American Home Products Corporation	Tricyclic pyrido vasopressin agonists
US6511974B1 (en)	1997-07-30	2003-01-28	Wyeth	Tricyclic vasopressin agonists
WO1999006409A1 (en) *	1997-07-30	1999-02-11	American Home Products Corporation	Tricyclic vasopressin agonists
US6090803A (en) *	1998-07-24	2000-07-18	American Home Products Corporation	Tricyclic vasopressin agonists
US7138393B2 (en) *	1998-07-24	2006-11-21	Wyeth	Biologically active vasopressin agonist metabolites
HU229074B1 (en) *	1999-01-19	2013-07-29	Ortho Mcneil Pharm Inc	Tricyclic benzodiazepines as vasopressin receptor antagonists
US6235900B1 (en)	1999-02-04	2001-05-22	American Home Products Corporation	Tricyclic pyridine N-oxides vasopressin agonists
AU2603000A (en) *	1999-02-04	2000-08-25	American Home Products Corporation	Thienylbenzoylbenzazepines as vasopressin agonists
US6620807B1 (en)	1999-02-04	2003-09-16	Wyeth	Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6297234B1 (en) *	1999-02-04	2001-10-02	American Home Products Corporation	Arylthiophene vasopressin agonists
US6344451B1 (en)	1999-02-04	2002-02-05	American Home Products	Pyrrolobenzodiazepine carboxyamide vasopressin agonists
CN1391476A (en) *	1999-09-27	2003-01-15	美国氰胺公司	Vasopressin agonist formulation and process
AU2002256685B2 (en) *	2001-03-20	2008-01-24	Merck Serono Sa	Pyrrolidine ester derivatives with oxytocin modulating acitvity
US6977254B2 (en) *	2001-04-12	2005-12-20	Wyeth	Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6900200B2 (en)	2001-04-12	2005-05-31	Wyeth	Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7064120B2 (en) *	2001-04-12	2006-06-20	Wyeth	Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7109193B2 (en) *	2001-04-12	2006-09-19	Wyeth	Tricyclic diazepines tocolytic oxytocin receptor antagonists
US7022699B2 (en)	2001-04-12	2006-04-04	Wyeth	Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7202239B2 (en) *	2001-04-12	2007-04-10	Wyeth	Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US6903087B2 (en) *	2001-04-12	2005-06-07	Wyeth	Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
CN1516589A (en) *	2001-04-12	2004-07-28		N-biphenylcarbonyl-anjd N-phenylpyridylcarbonyl substituted bi-and tricyclic azepines and diazepines as vasopressing agonists
EP1381608B1 (en) *	2001-04-12	2007-10-10	Wyeth	Cyclohexylphenyl vasopressin agonists
US7326700B2 (en) *	2001-04-12	2008-02-05	Wyeth	Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
WO2003037901A1 (en) *	2001-10-29	2003-05-08	Ortho-Mcneil Pharmaceutical, Inc.	Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists
US7119088B2 (en) *	2003-02-19	2006-10-10	Pfizer Inc.	Triazole compounds useful in therapy
EP2061795B1 (en) *	2006-08-14	2014-01-15	Council of Scientific & Industrial Research	Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof
ME02340B (en)	2008-06-10	2017-02-20	Abbvie Inc	Tricyclic compounds
SI2356123T1 (en)	2008-11-13	2013-01-31	F. Hoffmann-La Roche Ag	Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzosecazulenes
SG171742A1 (en)	2008-11-18	2011-07-28	Hoffmann La Roche	Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
EP2370441B1 (en)	2008-11-28	2013-09-11	F. Hoffmann-La Roche AG	Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin v1a receptor antagonists
UY33071A (en)	2009-12-01	2011-05-31	Abbott Lab	NEW TRICYCLIC COMPOUNDS
AU2010326030A1 (en)	2009-12-01	2012-06-07	Abbvie Inc.	Novel tricyclic compounds
US8420633B2 (en)	2010-03-31	2013-04-16	Hoffmann-La Roche Inc.	Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en)	2010-04-13	2013-06-11	Hoffmann-La Roche Inc.	Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en)	2010-04-21	2013-07-23	Hoffmann-La Roche Inc.	Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en)	2010-04-26	2013-07-09	Hoffmann-La Roche Inc.	Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
AU2011261164A1 (en) *	2010-06-01	2012-12-13	The University Of Queensland	Haematopoietic-prostaglandin D2 synthase inhibitors
CN103288829A (en) *	2012-02-24	2013-09-11	中国科学院大连化学物理研究所	Method for synthesizing chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepino-5-one
WO2014060381A1 (en)	2012-10-18	2014-04-24	Bayer Cropscience Ag	Heterocyclic compounds as pesticides
US20150284380A1 (en)	2012-10-31	2015-10-08	Bayer Cropscience Ag	Novel heterocyclic compounds as pest control agents
ES2738493T3 (en)	2013-03-14	2020-01-23	Tolero Pharmaceuticals Inc	JAK2 and ALK2 inhibitors and methods for their use
US10550126B2 (en)	2015-10-16	2020-02-04	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11773106B2 (en)	2015-10-16	2023-10-03	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11365198B2 (en)	2015-10-16	2022-06-21	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11512092B2 (en)	2015-10-16	2022-11-29	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11524964B2 (en)	2015-10-16	2022-12-13	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
MX2018004605A (en)	2015-10-16	2018-11-29	Abbvie Inc	PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1, 2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLI DINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF.
CA3103995A1 (en)	2018-07-26	2020-01-30	Sumitomo Dainippon Pharma Oncology, Inc.	Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3763183A (en) *	1972-07-10	1973-10-02	Sterling Drug Inc	1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines
US4766108A (en) *	1986-12-04	1988-08-23	Smith Kline Beckman Corporation	Tyr-Arg-vasopressin antagonists
US5055448A (en) *	1987-06-25	1991-10-08	Medical College Of Ohio	Linear derivatives of arginine vasopressin antagonists
DK0382185T3 (en) *	1989-02-10	1994-07-04	Otsuka Pharma Co Ltd	Carbostyril derivatives
DE122009000062I2 (en) *	1989-10-20	2011-01-13	Otsuka Pharma Co Ltd	BENZOHETEROCYCLIC COMPOUNDS
US5258510A (en) *	1989-10-20	1993-11-02	Otsuka Pharma Co Ltd	Benzoheterocyclic compounds
US5070187A (en) *	1989-11-03	1991-12-03	Trustees Of Boston University	Pharmacologically effective antagonists of arginine-vasopressin
TW199153B (en) *	1990-08-07	1993-02-01	Dtsuka Seiyaku Kk
CA2066104C (en) *	1991-04-19	2003-05-27	Hidenori Ogawa	Benzazepine derivatives as vasopressin antagonists
EP0533242A3 (en) *	1991-09-16	1993-09-15	Merck & Co. Inc.	Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
US5204349A (en) *	1991-09-16	1993-04-20	Merck & Co., Inc.	Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
EP0533243B1 (en) *	1991-09-16	1997-12-17	Merck & Co. Inc.	Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives
EP0533240A3 (en) *	1991-09-16	1993-09-29	Merck & Co. Inc.	Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
AU657431B2 (en) *	1992-08-20	1995-03-09	Otsuka Pharmaceutical Co., Ltd.	Benzoheterocyclic compounds as oxytocin and vasopressin antagonists
WO1994012476A1 (en) *	1992-11-25	1994-06-09	Yamanouchi Pharmaceutical Co., Ltd.	Benzanilide derivative
WO1994014796A1 (en) *	1992-12-21	1994-07-07	Yamanouchi Pharmaceutical Co., Ltd.	Novel n-(pyridylcarbonyl)benzazepine derivative and intermediate therefor
AU6219994A (en) *	1993-03-11	1994-09-26	Yamanouchi Pharmaceutical Co., Ltd.	Compound with vasopressin antagonism
GB9307527D0 (en) *	1993-04-13	1993-06-02	Fujisawa Pharmaceutical Co	New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
US5516774A (en) *	1993-07-29	1996-05-14	American Cyanamid Company	Tricyclic diazepine vasopressin antagonists and oxytocin antagonists

1995
- 1995-01-17 US US08/373,125 patent/US5521173A/en not_active Expired - Lifetime
1996
- 1996-01-15 ZA ZA96303A patent/ZA96303B/en unknown
- 1996-01-15 AR ARP960101024A patent/AR002021A1/en unknown
- 1996-01-16 BR BR9607177A patent/BR9607177A/en not_active IP Right Cessation
- 1996-01-16 HU HU9702459A patent/HUP9702459A3/en unknown
- 1996-01-16 AU AU46566/96A patent/AU707881B2/en not_active Ceased
- 1996-01-16 NZ NZ301198A patent/NZ301198A/en unknown
- 1996-01-16 MX MX9705414A patent/MX9705414A/en not_active IP Right Cessation
- 1996-01-16 TW TW085100471A patent/TW472056B/en not_active IP Right Cessation
- 1996-01-16 ES ES96902143T patent/ES2175066T3/en not_active Expired - Lifetime
- 1996-01-16 UA UA97084248A patent/UA48960C2/en unknown
- 1996-01-16 IL IL11677496A patent/IL116774A/en not_active IP Right Cessation
- 1996-01-16 WO PCT/US1996/000515 patent/WO1996022292A1/en not_active Application Discontinuation
- 1996-01-16 EP EP96902143A patent/EP0805813B1/en not_active Expired - Lifetime
- 1996-01-16 CZ CZ972247A patent/CZ224797A3/en unknown
- 1996-01-16 DE DE69621225T patent/DE69621225T2/en not_active Expired - Fee Related
- 1996-01-16 JP JP52234496A patent/JP4156664B2/en not_active Expired - Fee Related
- 1996-01-16 CA CA002210708A patent/CA2210708C/en not_active Expired - Fee Related
- 1996-01-16 PT PT96902143T patent/PT805813E/en unknown
- 1996-01-16 EA EA199700118A patent/EA000056B1/en not_active IP Right Cessation
- 1996-01-16 DK DK96902143T patent/DK0805813T3/en active
- 1996-01-16 CN CN96192570A patent/CN1052725C/en not_active Expired - Fee Related
- 1996-01-16 AT AT96902143T patent/ATE217625T1/en not_active IP Right Cessation
- 1996-05-23 US US08/652,198 patent/US5780471A/en not_active Expired - Lifetime
1998
- 1998-04-16 HK HK98103196A patent/HK1003891A1/en not_active IP Right Cessation
2007
- 2007-11-21 JP JP2007301897A patent/JP2008069176A/en not_active Withdrawn

Also Published As

Publication number	Publication date
TW472056B (en)	2002-01-11
JPH11500424A (en)	1999-01-12
AU707881B2 (en)	1999-07-22
CN1178532A (en)	1998-04-08
MX9705414A (en)	1997-11-29
PT805813E (en)	2002-10-31
AR002021A1 (en)	1998-01-07
ATE217625T1 (en)	2002-06-15
NZ301198A (en)	1999-08-30
JP4156664B2 (en)	2008-09-24
EP0805813B1 (en)	2002-05-15
DE69621225T2 (en)	2002-11-14
AU4656696A (en)	1996-08-07
US5780471A (en)	1998-07-14
HUP9702459A3 (en)	2000-08-28
ES2175066T3 (en)	2002-11-16
EA199700118A1 (en)	1997-12-30
EP0805813A1 (en)	1997-11-12
EA000056B1 (en)	1998-04-30
BR9607177A (en)	1997-11-11
DK0805813T3 (en)	2002-08-05
WO1996022292A1 (en)	1996-07-25
IL116774A0 (en)	1996-05-14
CN1052725C (en)	2000-05-24
CA2210708C (en)	2005-05-24
CA2210708A1 (en)	1996-07-25
HK1003891A1 (en)	1998-11-13
IL116774A (en)	2000-12-06
UA48960C2 (en)	2002-09-16
US5521173A (en)	1996-05-28
HUP9702459A2 (en)	1998-05-28
JP2008069176A (en)	2008-03-27
DE69621225D1 (en)	2002-06-20
CZ224797A3 (en)	1998-03-18

Publication	Publication Date	Title
HK1004132A1 (en)	1998-11-20	Tricyclic benzazepine vasopressin antagonists
ZA96303B (en)	1997-07-15	Tricyclic benzazepine vasopressin antagonists
ZA96300B (en)	1997-07-15	Tricyclic benzazepine vasopressin antagonists
IL127470A0 (en)	1999-10-28	Tricyclic benzazepine vasopressin antagonists
ZA96299B (en)	1997-07-15	Tricyclic benzazepine vasopressin antagonists
IL116777A0 (en)	1996-05-14	Tricyclic benzazepine vasopressin antagonists and their preparation
ZA96298B (en)	1997-07-15	Tricyclic benzazepine vasopressin antagonists
HK1016973A1 (en)	1999-11-12	Benzazepine derivatives with vasopressin agonistic activity
IL133788A0 (en)	2001-04-30	Tricyclic vasopressin agonists
IL144270A0 (en)	2002-05-23	Tricyclic benzodiazepines as vasopressin receptor antagonists
HU9601176D0 (en)	1996-06-28	Adhesion-receptor antagonists
AU5844896A (en)	1996-12-18	Tricyclic diazepines useful as gnrh receptor antagonists
AU3641497A (en)	1998-01-14	Tricyclic benzazepine vasopressin antagonists
HK1018057A1 (en)	1999-12-10	Tricyclic benzazepine compounds
AU3296597A (en)	1998-01-07	Tricyclic benzazepine vasopressin antagonists
IL118299A0 (en)	1996-09-12	Pharmacological use of AII-receptor antagonists
AU3296497A (en)	1998-01-07	Tricyclic benzazepine vasopressin antagonists
SI0804438T1 (en)	2006-08-31	Tricyclic benzazepine vasopressin antagonists
GB9525388D0 (en)	1996-02-14	Benzazepine derivatives
GB9525365D0 (en)	1996-02-14	Benzazepine derivatives
ZA961293B (en)	1996-08-19	Muscarinic antagonists
GB9507788D0 (en)	1995-05-31	Antitumour compounds